Search Results - Jonas Waizenegger
- Showing 1 - 3 results of 3
-
1
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) by Sarah Krause, Christian Pfeiffer, S Strube, Ameera Alsadeq, Henning Fedders, Christian Vokuhl, Sonja Loges, Jonas Waizenegger, Isabel Ben‐Batalla, Gunnar Cario, Anja Möricke, Martin Stanulla, Martin Schrappe, Denis M. Schewe
Published 2014Artigo -
2
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma by Isabel Ben‐Batalla, Alexander Schultze, Mark Wroblewski, Robert Erdmann, Michael Heuser, Jonas Waizenegger, Kristoffer Riecken, Mascha Binder, Denis M. Schewe, Stefanie Sawall, Victoria Witzke, Miguel Cubas‐Cordova, Melanie Janning, Jasmin Wellbrock, Boris Fehse, Christian Hagel, Jürgen Krauter, Arnold Ganser, James B. Lorens, Walter Fiedler, Peter Carmeliet, Klaus Pantel, Carsten Bokemeyer, Sonja Loges
Published 2013Artigo -
3
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial by Sonja Loges, Michael Heuser, Jörg Chromik, Grerk Sutamtewagul, Silke Kapp‐Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto M. Lemoli, Daniele Mattei, Walter Fiedler, Yesid Alvarado‐Valero, Isabel Ben‐Batalla, Jonas Waizenegger, Lisa-Marie Rieckmann, Melanie Janning, Maike Collienne, Charles D. Imbusch, Niklas Beumer, David Micklem, Linn Nilsson, Noëlly Madeleine, Nigel McCracken, Cristina Oliva, Claudia Gorcea-Carson, Bjørn Tore Gjertsen
Published 2025Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Biology
Bone marrow
Cancer research
Chemotherapy
Immunology
Leukemia
Myeloid leukemia
Receptor
Acute lymphocytic leukemia
Adverse effect
Biochemistry
Central nervous system
Combination therapy
Cytarabine
Cytopenia
Febrile neutropenia
Fms-Like Tyrosine Kinase 3
Gene
Lymphoblastic Leukemia
Mutation
Neutropenia
Oncology
Paracrine signalling
Pharmacology
Stromal cell
Tolerability
Tumor lysis syndrome
Tyrosine kinase